Epicardially Placed Bioengineered Cardiomyocyte Xenograft in Immune-Competent Rat Model of Heart Failure

BACKGROUND: Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) are under preclinical investigation as a cell-based therapy for heart failure post-myocardial infarction. In a previous study, tissue-engineered cardiac grafts were found to improve hosts' cardiac electrical and...

Descripción completa

Detalles Bibliográficos
Autores principales: Chinyere, Ikeotunye Royal, Bradley, Pierce, Uhlorn, Joshua, Eason, Joshua, Mohran, Saffie, Repetti, Giuliana G., Daugherty, Sherry, Koevary, Jen Watson, Goldman, Steven, Lancaster, Jordan J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8325579/
https://www.ncbi.nlm.nih.gov/pubmed/34341667
http://dx.doi.org/10.1155/2021/9935679

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8325579/
https://www.ncbi.nlm.nih.gov/pubmed/34341667
http://dx.doi.org/10.1155/2021/9935679

Ejemplares similares